In conclusion, as proposal model shown in Fig. 8, we found dysregulation of STAT5A/miR-202-5p/USP15/Caspase-6 regulatory axis contributed to CML cell apoptosis and Imatinib resistance. The gene discussed is CASP6; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.